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Background/introduction
While most brain tumors do not have an intact blood-
brain barrier (BBB), vascular barriers in the tumor and
the surrounding intact brain tissue are major challenges
for the use of chemotherapy for CNS malignancies. The
permeability of brain tumor vessels can be highly hetero-
geneous, and factors such as high interstitial pressures
can prevent agents from reaching an effective concentra-
tion in all tumor regions. Furthermore, tumors such as
glioma are highly infiltrative, and these infiltrating tumor
cells in the brain tissue surrounding the vascular portion
of the tumor are protected by the BBB.
Methods
Numerous studies have demonstrated that when com-
bined with an ultrasound contrast agent, ultrasound can
temporarily disrupt the BBB and increase the delivery of
agents across the “blood-tumor barrier”. This presentation
will review data obtained in rat and mice brain tumor
models that evaluated tumor growth rates and survival
after ultrasound-enhanced chemotherapy delivery. These
studies have evaluated a range of primary and metastatic
models and drugs.
Results and conclusions
These studies have all demonstrated that ultrasound-
induced permeabilization of the BTB and chemotherapy
can improve outcomes in rodent and human tumor mod-
els. Drugs including BCNU, doxorubicin (both free and
liposomal), temozolimide, and trastuzumab have been
tested. While in some cases the response has been modest,
with multiple treatments dramatic improvements have
been reported.
These studies demonstrate the potential for this technol-
ogy, either alone or in combination with focused ultrasound
ablation, to provide more effective treatment options for
patients with brain tumors. The next steps needed for clini-
cal translation, including the need for tests in better tumor
models, improvements to transcranial focused ultrasound
systems to enable sonication of large volumes, and the
development of effective methods to monitor and guide the
procedure outside the MRI will be discussed.
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